Regorafenib for treatment of advanced gastrointestinal stromal tumors.
about
Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies.The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).The safety of regorafenib for the treatment of gastrointestinal stromal tumors.
P2860
Regorafenib for treatment of advanced gastrointestinal stromal tumors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Regorafenib for treatment of advanced gastrointestinal stromal tumors.
@en
type
label
Regorafenib for treatment of advanced gastrointestinal stromal tumors.
@en
prefLabel
Regorafenib for treatment of advanced gastrointestinal stromal tumors.
@en
P2860
P1476
Regorafenib for treatment of advanced gastrointestinal stromal tumors
@en
P2093
Lindsay C Overton
P2860
P304
P356
10.1517/14656566.2014.877888
P407
P577
2014-01-10T00:00:00Z